EPHB2 and breast carcinoma: For example, Noren et al have shown that EphB2 receptor tyrosine kinase acts as a tumor suppressor in breast cancer cells and that depletion of EphB2 or its ligand ephrinB2 prediposes breast cancer cells to invasion and metastasis [31].